9th Call for Proposals 2013 - Innovative Medicines Initiative IMI-CALL-2013-9 Closed!

Objectives

 The Innovative Medicines Initiative Joint Undertaking (IMI JU) is a unique pan-European public private partnership aiming to foster collaboration between all relevant stakeholders including large and small biopharmaceutical and healthcare companies, regulators, academia, and patients. The aim of IMI is to support pre-competitive pharmaceutical research and development (R&D) to foster the development of safe and more effective medicines for patients through removing identified bottlenecks in the drug development process, and to enhance Europe’s competitiveness by ensuring that its biopharmaceutical sector remains a dynamic high-technology sector.

Actions

 The IMI 9th Call 2012 for proposals will have 2 topics covering the following key research priorities:

  • WEBAE – Leveraging Emerging Technologies for Pharmacovigilance
  • Developing Innovative Therapeutic Interventions Against Physical Frailty and Sarcopenia (ITI-PF&S) as a Prototype Geriatric Indication
 

European community funding

The Community provisional funding available for the call for proposals is:

  • 135,37 Million EUR (Global Budget)

All the important deadlines

  • 09 October 2013 - 6 years ago (Deadline for the presentation of proposals)

Further information about the call

Useful documents

  • Call for proposals (Legal base)

Organisations eligible to participate

Opened to the following bodies or institutes with legal status established in the covered areas:

  • Any legal organisation

Covered areas

Bodies or institutes must have their registered legal seat in one of the countries taking part in the Programme which are:

  • European Union (EU)

Directorate-Generale responsible

Directorate-General for Research

Related calls for proposals

Related calls

Explore other programmes